Skip to content
Recall Observatory FDA recall evidence

Drug product

Lisinopril and Hydrochlorothiazide Tablets USP, 10 mg/12.5 mg, 100 tablet bottle, Rx only, Manufactured by for: Lupin Pharmaceuticals, Inc., Baltimore, MD, Manufactured by: Lupin Limited, Pithampur, INDIA NDC 68180-518-01

D-1720-2019

July 17, 2019

Class II

Product summary

Firm
Lupin Pharmaceuticals Inc.
Event
Event 83354
Status
Terminated
Classification
Class II
Quantity
39,216 bottles
Official record key
drug-enforcement:D-1720-2019

Official wording

Reason: Presence of Foreign Substance; Product complaints received related to brownish/blackish stains on the tablets and brownish/blackish powder observed inside the bottles.

Code information: Batch# H900575, exp. date 01/2022

Distribution pattern: Product was distributed to wholesalers/distributors and supermarket and drug chains throughout the United States.

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    Foreign Substance